To include your compound in the COVID-19 Resource Center, submit it here.

SPK-FIX: Phase I/II data

Top-line data from the first 3 severe hemophilia B patients in an open-label, dose-escalation, U.S. Phase I/II trial showed that a single dose of 5x10^11 vg/kg IV SPK-9001

Read the full 285 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE